Selected research
Industry Research
Sertraline HCl Industry Research Report 2026
Market perspective
The global Sertraline HCl market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sertraline HCl is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sertraline HCl is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sertraline HCl is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sertraline HCl include Teva, Sun Pharmaceutical, Novartis, Mylan, Pfizer, Wockhardt, Unimarck Pharma India Pvt Ltd, Torrent Pharma and Tanabe Mitsubishi Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sertraline HCl market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sertraline HCl Market by Company
Teva
Sun Pharmaceutical
Novartis
Mylan
Pfizer
Wockhardt
Unimarck Pharma India Pvt Ltd
Torrent Pharma
Tanabe Mitsubishi Pharma
Lupin
Jing Xin Pharm
InvaGen
Genericon Pharma
G.L. Pharma
Daiichi-Sankyo
Aurobindo Pharma USA
Apotex
Alpic Biotech
Accord Healthcare
Sertraline HCl Segment by Type
20 mg
25 mg
50 mg
100 mg
Sertraline HCl Segment by Application
OCD
Premenstrual Anxiety Disorder
Panic Disorder
Depression
Other Indications
Sertraline HCl Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sertraline HCl market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sertraline HCl and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sertraline HCl.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sertraline HCl manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sertraline HCl by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sertraline HCl in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20 mg
- 25 mg
- 50 mg
- 100 mg
Applications
- OCD
- Premenstrual Anxiety Disorder
- Panic Disorder
- Depression
- Other Indications
Companies covered
- Teva
- Sun Pharmaceutical
- Novartis
- Mylan
- Pfizer
- Wockhardt
- Unimarck Pharma India Pvt Ltd
- Torrent Pharma
- Tanabe Mitsubishi Pharma
- Lupin
- Jing Xin Pharm
- InvaGen
- Genericon Pharma
- G.L. Pharma
- Daiichi-Sankyo
- Aurobindo Pharma USA
- Apotex
- Alpic Biotech
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sertraline HCl Market Size (2021-2032)
- 2.2.2 Global Sertraline HCl Sales (2021-2032)
- 2.2.3 Global Sertraline HCl Market Average Price (2021-2032)
- 2.3 Sertraline HCl by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20 mg
- 2.3.3 25 mg
- 2.3.4 50 mg
- 2.3.5 100 mg
- 2.4 Sertraline HCl by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 OCD
- 2.4.3 Premenstrual Anxiety Disorder
- 2.4.4 Panic Disorder
- 2.4.5 Depression
- 2.4.6 Other Indications
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sertraline HCl Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sertraline HCl Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Sertraline HCl Revenue of Manufacturers (2021-2026)
- 3.4 Global Sertraline HCl Average Price by Manufacturers (2021-2026)
- 3.5 Global Sertraline HCl Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sertraline HCl, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sertraline HCl, Product Type & Application
- 3.8 Global Manufacturers of Sertraline HCl, Established Date
- 3.9 Global Sertraline HCl Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Sertraline HCl Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Sertraline HCl Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Sertraline HCl Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Sertraline HCl Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Sertraline HCl Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Wockhardt
- 4.6.1 Wockhardt Company Information
- 4.6.2 Wockhardt Business Overview
- 4.6.3 Wockhardt Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wockhardt Sertraline HCl Product Portfolio
- 4.6.5 Wockhardt Recent Developments
- 4.7 Unimarck Pharma India Pvt Ltd
- 4.7.1 Unimarck Pharma India Pvt Ltd Company Information
- 4.7.2 Unimarck Pharma India Pvt Ltd Business Overview
- 4.7.3 Unimarck Pharma India Pvt Ltd Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Unimarck Pharma India Pvt Ltd Sertraline HCl Product Portfolio
- 4.7.5 Unimarck Pharma India Pvt Ltd Recent Developments
- 4.8 Torrent Pharma
- 4.8.1 Torrent Pharma Company Information
- 4.8.2 Torrent Pharma Business Overview
- 4.8.3 Torrent Pharma Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Torrent Pharma Sertraline HCl Product Portfolio
- 4.8.5 Torrent Pharma Recent Developments
- 4.9 Tanabe Mitsubishi Pharma
- 4.9.1 Tanabe Mitsubishi Pharma Company Information
- 4.9.2 Tanabe Mitsubishi Pharma Business Overview
- 4.9.3 Tanabe Mitsubishi Pharma Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Tanabe Mitsubishi Pharma Sertraline HCl Product Portfolio
- 4.9.5 Tanabe Mitsubishi Pharma Recent Developments
- 4.10 Lupin
- 4.10.1 Lupin Company Information
- 4.10.2 Lupin Business Overview
- 4.10.3 Lupin Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lupin Sertraline HCl Product Portfolio
- 4.10.5 Lupin Recent Developments
- 4.11 Jing Xin Pharm
- 4.11.1 Jing Xin Pharm Company Information
- 4.11.2 Jing Xin Pharm Business Overview
- 4.11.3 Jing Xin Pharm Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jing Xin Pharm Sertraline HCl Product Portfolio
- 4.11.5 Jing Xin Pharm Recent Developments
- 4.12 InvaGen
- 4.12.1 InvaGen Company Information
- 4.12.2 InvaGen Business Overview
- 4.12.3 InvaGen Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 InvaGen Sertraline HCl Product Portfolio
- 4.12.5 InvaGen Recent Developments
- 4.13 Genericon Pharma
- 4.13.1 Genericon Pharma Company Information
- 4.13.2 Genericon Pharma Business Overview
- 4.13.3 Genericon Pharma Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Genericon Pharma Sertraline HCl Product Portfolio
- 4.13.5 Genericon Pharma Recent Developments
- 4.14 G.L. Pharma
- 4.14.1 G.L. Pharma Company Information
- 4.14.2 G.L. Pharma Business Overview
- 4.14.3 G.L. Pharma Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 G.L. Pharma Sertraline HCl Product Portfolio
- 4.14.5 G.L. Pharma Recent Developments
- 4.15 Daiichi-Sankyo
- 4.15.1 Daiichi-Sankyo Company Information
- 4.15.2 Daiichi-Sankyo Business Overview
- 4.15.3 Daiichi-Sankyo Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Daiichi-Sankyo Sertraline HCl Product Portfolio
- 4.15.5 Daiichi-Sankyo Recent Developments
- 4.16 Aurobindo Pharma USA
- 4.16.1 Aurobindo Pharma USA Company Information
- 4.16.2 Aurobindo Pharma USA Business Overview
- 4.16.3 Aurobindo Pharma USA Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Aurobindo Pharma USA Sertraline HCl Product Portfolio
- 4.16.5 Aurobindo Pharma USA Recent Developments
- 4.17 Apotex
- 4.17.1 Apotex Company Information
- 4.17.2 Apotex Business Overview
- 4.17.3 Apotex Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Apotex Sertraline HCl Product Portfolio
- 4.17.5 Apotex Recent Developments
- 4.18 Alpic Biotech
- 4.18.1 Alpic Biotech Company Information
- 4.18.2 Alpic Biotech Business Overview
- 4.18.3 Alpic Biotech Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Alpic Biotech Sertraline HCl Product Portfolio
- 4.18.5 Alpic Biotech Recent Developments
- 4.19 Accord Healthcare
- 4.19.1 Accord Healthcare Company Information
- 4.19.2 Accord Healthcare Business Overview
- 4.19.3 Accord Healthcare Sertraline HCl Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Accord Healthcare Sertraline HCl Product Portfolio
- 4.19.5 Accord Healthcare Recent Developments
5 Global Sertraline HCl Market Scenario by Region
- 5.1 Global Sertraline HCl Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sertraline HCl Sales by Region: 2021-2032
- 5.2.1 Global Sertraline HCl Sales by Region: 2021-2026
- 5.2.2 Global Sertraline HCl Sales by Region: 2027-2032
- 5.3 Global Sertraline HCl Revenue by Region: 2021-2032
- 5.3.1 Global Sertraline HCl Revenue by Region: 2021-2026
- 5.3.2 Global Sertraline HCl Revenue by Region: 2027-2032
- 5.4 North America Sertraline HCl Market Facts & Figures by Country
- 5.4.1 North America Sertraline HCl Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sertraline HCl Sales by Country (2021-2032)
- 5.4.3 North America Sertraline HCl Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Sertraline HCl Market Facts & Figures by Country
- 5.5.1 Europe Sertraline HCl Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sertraline HCl Sales by Country (2021-2032)
- 5.5.3 Europe Sertraline HCl Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Sertraline HCl Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sertraline HCl Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sertraline HCl Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sertraline HCl Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sertraline HCl Market Facts & Figures by Country
- 5.7.1 South America Sertraline HCl Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sertraline HCl Sales by Country (2021-2032)
- 5.7.3 South America Sertraline HCl Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Sertraline HCl Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sertraline HCl Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sertraline HCl Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sertraline HCl Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Sertraline HCl Sales by Type (2021-2032)
- 6.1.1 Global Sertraline HCl Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Sertraline HCl Sales Market Share by Type (2021-2032)
- 6.2 Global Sertraline HCl Revenue by Type (2021-2032)
- 6.2.1 Global Sertraline HCl Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sertraline HCl Revenue Market Share by Type (2021-2032)
- 6.3 Global Sertraline HCl Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sertraline HCl Sales by Application (2021-2032)
- 7.1.1 Global Sertraline HCl Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Sertraline HCl Sales Market Share by Application (2021-2032)
- 7.2 Global Sertraline HCl Revenue by Application (2021-2032)
- 7.2.1 Global Sertraline HCl Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sertraline HCl Revenue Market Share by Application (2021-2032)
- 7.3 Global Sertraline HCl Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sertraline HCl Value Chain Analysis
- 8.1.1 Sertraline HCl Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sertraline HCl Production Mode & Process
- 8.2 Sertraline HCl Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sertraline HCl Distributors
- 8.2.3 Sertraline HCl Customers
9 Global Sertraline HCl Analyzing Market Dynamics
- 9.1 Sertraline HCl Industry Trends
- 9.2 Sertraline HCl Industry Drivers
- 9.3 Sertraline HCl Industry Opportunities and Challenges
- 9.4 Sertraline HCl Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst